TLSI – trisalus life sciences, inc. (US:NASDAQ)
Stock Stats
News
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $10.00 price target on the stock.
TriSalus Life Sciences, Inc. (TLSI) Q2 2024 Earnings Call Transcript [Seeking Alpha]
TriSalus Reports Q2 2024 Financial Results and Business Update
TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call
TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation [Yahoo! Finance]
Form 4 TriSalus Life Sciences, For: Sep 12 Filed by: Szela Mary T
Form 4 TriSalus Life Sciences, For: Sep 10 Filed by: Szela Mary T
Form 4 TriSalus Life Sciences, For: Aug 28 Filed by: Martin George Kelly
Form 4 TriSalus Life Sciences, For: Aug 13 Filed by: Wahlstrom Mats
Form 4 TriSalus Life Sciences, For: Aug 13 Filed by: Hyveled Liselotte
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.